Zoetis Inc. (NYSE:ZTS) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
dividend of $0.105 per share for the second quarter of 2017. The
dividend will be paid on June 1, 2017 to all holders of record of
the Companys common stock as of the close of business on April 6,
2017.
99.1, shall not be deemed filed for purposes of the Securities
Exchange Act of 1934, as amended, or incorporated by reference in
any filing under the Securities Act of 1933, as amended,
regardless of any general incorporation language in such filing,
unless expressly incorporated by specific reference in such
filing.
|
(d)
|
Exhibit:
|
About Zoetis Inc. (NYSE:ZTS)
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness. Zoetis Inc. (NYSE:ZTS) Recent Trading Information
Zoetis Inc. (NYSE:ZTS) closed its last trading session down -0.12 at 55.02 with 5,216,391 shares trading hands.